1Casey DG,Lysaght J,James T,et al.Hr 〈 tt shock protein derived from a non-autologous tumour can he used as an anti -tumour vaccine[J].Immunology,2003,110 (1):105-111.
2Broquet AH,Thomas G,Masliah J,et al.Expression of the molecular chaperone Hsp70 in detergent-resistantmicrodomains correlates with itsrxmbrane delivery and release[J].J Biol Chem,2003,278 (24):21601 -21606.
4Harmala LA,Ingulli EG,Curtsinger JM,et al.The adjuvant effects of My-cobacterium tu6erculasis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8 + T cells in vivo[J].J Immunol,2002,169(10):5622 -5629.
6Suaue K,Young RA.Adjuvant-free hsp 70 fusion protein system elicits humnaal and cellular immune responses to HIV-Ⅰ p24[J].J Immunol,1996,156 (2):873-879.
7Chen CH,Wang TL,Hung CL,et al.Enhancement of DNA vaccine po -tency by linkage of antigen gene to a hsp70 gene[J].Cancer Research,2000,60(4):1035-1042.
8Hsu KF,Hung CF,Cheng WF,et al.Enhancement of suicidal DNA vac-cine potency by linking mycobacterium tuberculosis heat shock protein70 an antigen[J].Gene Ther,2001,8 (5):376-383.
9Vanaja DK,Grossmenn ME,Celts E,et al.Tumor prevention and antihi-mor immunity with heat shock protein 70 induced by 15 -deltal2,14-prostaglandin J2 in transgene adenocancinoma of mouse pmtate cells[J].Caner Res,2000,60(17):4714 -4716.
10Biragyn A,Tani K,Grimm MC,et al.Genetic fusion ofchemokines to a selftumor antigen induces protective,T-cell dependent antitumorimmunity[J].Nat Biotechnol,1999,17 (3):253-258.
